NKTR
Nektar Therapeutics · Healthcare
Chief R, D Officer Jonathan Zalevsky sold $138K of Nektar Therapeutics
Sold$137,936
$35.67Price
3,867Shares
−15%Stake
What NKTR did after the filing
- The stock from Thu, Jan 22 close, $36.53
- +93.5%
- S&P 500, same days
- −2.4%
Measured over 30 trading days, to the Mar 6 close.
Traded Tue, Jan 20. Filed Thu, Jan 22, 2:31 PM ET, during the session. Returns use the Jan 22 close and the Mar 6 close. Not investment advice.